FDA Drug Application (021254) for ADVAIR HFA by GLAXO GRP LTD

Back to FDA Applications sponsored by GLAXO GRP LTD

Application Number021254
Product Number001
FormAEROSOL, METERED;INHALATION
Dosage0.045MG/INH;EQ 0.021MG BASE/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameADVAIR HFA
Active IngredientFLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Active IngredientCount
List of drugs with Active Ingredient FLUTICASONE PROPIONATE14
List of drugs with Active Ingredient SALMETEROL XINAFOATE5


Back to FDA Applications sponsored by GLAXO GRP LTD